Ravi Kumar Anchoori
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2021First federal award
$2.8MFederal grants as PI5 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
5 awards · $2.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 31, 2024 | NIH | SBIR Phase II Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients | $1.2M | Up Therapeutics LLC |
| Aug 30, 2023 | NIH | SBIR Phase II Development of a novel small molecule RPN13 inhibitor and therapeutic for advanced ovarian cancer patients | $868K | Up Therapeutics LLC |
| Aug 23, 2022 | NIH | STTR Phase I Development of small molecule RPN13 inhibitors for Treatment of Glioblastoma | $400K | Up Therapeutics LLC |
| Mar 7, 2022 | NIH | STTR Phase I Developing a RPN13 inhibitor for the treatment of Quadruple Negative Breast Cancer | $55K | Up Therapeutics LLC |
| Apr 1, 2021 | NIH | STTR Phase I Developing a RPN13 inhibitor for the treatment of Quadruple Negative Breast Cancer | $254K | Up Therapeutics LLC |
Peer ranks
Federal funding#691
Awards as PI#417
Patents#273
Companies
- Up Therapeutics LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.